Fatigue und kognitive Beeinträchtigungen bei der MS

Zusammenfassung

Die Multiple Sklerose (MS): das Chamäleon in der Neurologie. Sie kann sehr unterschiedliche Symptome annehmen. Daher lässt sie sich nicht nach einem einheitlichen Schema (Schema F) behandeln. Vielleicht noch mehr als bei anderen neurologischen Erkrankungen kommt es darauf an, das individuelle Defizit und Partizipationsziel des Patienten zu erfassen. Aufgrund der motorischen Defizite sind Physio- und Ergotherapeuten gefragt, und sie werden häufig mit Formen der kognitiven und motorischen Fatigue konfrontiert. Der enge und regelmäßige Kontakt mit dem Patienten macht die Therapeuten zu Coaches und Trainern – eine Rolle, die ein hohes Maß an Wissen, Verantwortung und Kompetenz voraussetzt. Motorische Therapeuten können die Fatigue beeinflussen; wie, lesen Sie jetzt in der neuroreha.

• Literatur

• 1 Benedict RH et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 2002; 16: 381-397
• 2 Chiaravalloti ND, DeLuca J.. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7: 1139-1151
• 3 Claros-Salinas D et al. Fatigue-related diurnal variations of cognitive performance in multiple sclerosis and stroke patients. J Neurol Sci 2010; 295: 75-81
• 4 Dalgas U et al. Fatigue, mood and quality of life improve in MS patients after progressive resistance training. Mult Scler 2010; 16: 480-490
• 5 DeLuca J.. Fatigue, cognition, and mental effort. DeLuca J.. Fatigue as a window to the brain. Cambridge: MIT Press; 2005: 37-57
• 6 Dettmers C et al. Endurance exercise improves walking distance in MS patients with fatigue. Acta Neurol Scand 2009; 120: 251-257
• 7 Dineen RA et al. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 2009; 132: 239-249
• 8 Felbecker A et al. Einfluß körperlicher Aktivität auf kognitive Fähigkeiten bei der Multiplen Sklerose. Neurol Rehabil 2013; 19: 227-235
• 9 Filippi M, Rocca MA. Toward a definition of structural and functional MRI substrates of fatigue in multiple sclerosis. J Neurol Sci 2007; 263: 1-2
• 10 Filippi M et al. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 2002; 15: 559-567
• 11 Fisk JD et al. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994; 21: 9-14
• 12 Flachenecker P et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 2002; 8: 523-526
• 13 Genova HM et al. Examination of Cognitive Fatigue in Multiple Sclerosis using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging. PLOS ONE 2013; 8: e78811-e78811
• 14 Gottschalk M et al. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch Neurol 2005; 62: 277-280
• 15 Greim B, Benecke R, Zettl UK. Qualitative and quantitative assessment of fatigue in multiple sclerosis (MS). J Neurol 2007; 254 (Suppl. 02) II58-II64
• 16 Greim B et al. Fatigue in neuroimmunological diseases. J Neurol 2007; 254 (Suppl. 02) II102-II106
• 17 Hildebrandt H.. Fatigue bei Multipler Sklerose – gemeinsames Endstreckensyndrom einer Dysfunktion im Bereich des Nucleus tuberomamillaris?. Neurologie & Rehabilitation 2012; 18: 117-125
• 18 Holberg C, Finlayson M. Factors influencing the use of energy conservation strategies by persons with multiple sclerosis. Am J Occup Ther 2007; 61: 96-107
• 19 Iaffaldano P et al. Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. PLOS ONE 2012; 7: e35843-e35843
• 20 Induruwa I. Constantinescu CS, Gran B. Fatigue in multiple sclerosis – a brief review. J Neurol Sci 2012; 323: 9-15
• 21 Kluger BM et al. Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy. Neurology 2013; 80: 409-416
• 22 Kroencke DC, Lynch SG, Denney DR. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Mult Scler 2000; 6: 131-136
• 23 Langdon DW. Cognition in multiple sclerosis. Curr Opin Neurol 2011; 24: 244-249
• 24 Langdon DW et al. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler 2012; 18: 891-898
• 25 Mathiowetz VG et al. One-year follow-up to a randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Int J Rehabil Res 2007; 30: 305-313
• 26 Mills RJ, Young CA. A medical definition of fatigue in multiple sclerosis. QJM 2008; 101: 49-60
• 27 Mills RJ, Young CA. The relationship between fatigue and other clinical features of multiple sclerosis. Mult Scler 2011; 17: 604-612
• 28 Motl RW, Gosney JL. Effect of exercise training on quality of life in multiple sclerosis: a meta-analysis. Mult Scler 2008; 14: 129-135
• 29 Naess H, Lunde L, Brogger J. The effects of fatigue, pain, and depression on quality of life in ischemic stroke patients: the Bergen Stroke Study. Vasc Health Risk Manag 2012; 8: 407-413
• 30 Naess H et al. Fatigue among stroke patients on long-term follow-up. The Bergen Stroke Study. J Neurol Sci 2012; 312: 138-141
• 31 Neumann M. Bestimmung kognitiver Fatigue bei Patienten mit Multipler Sklerose mit einem kognitiven Belastungstest. 2014; Promotionsarbeit Magedeburg, Medizinische Fakultät
• 32 Niepel G et al. Deep gray matter and fatigue in MS: a T1 relaxation time study. J Neurol 2006; 253: 896-902
• 33 Nocentini U et al. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis. Brain Imaging Behav 2012;
• 34 Patti F et al. Subcutaneous interferon beta-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-Year Follow-up of the COGIMUS Study. PLOS ONE 2013; 8: e74111-e74111
• 35 Penner I, Calabrese P. Managing fatigue: clinical correlates, assessment procedures and therapeutic strategies. Int MS J 2010; 17: 28-34
• 36 Penner IK et al. Fatigue in multiple sclerosis: relation to depression, physical impairment, personality and action control. Mult Scler 2007; 13: 1161-1167
• 37 Penner IK et al. The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler 2009; 15: 1509-1517
• 38 Rossi F et al. Relevance of brain lesion location to cognition in relapsing multiple sclerosis. PLOS ONE 2012; 7: e44826-e44826
• 39 Schlaeger R, Fuhr P. Symptomatische medikamentöse Behandlung der Fatigue. Penner I.K.. Fatigue bei Multipler Sklerose. Grundlagen, Klinik, Diagnostik, Therapie. 2009. Hippocampus Verlag;
• 40 Sehle A et al. Objective assessment of motor fatigue in multiple sclerosis using kinematic gait analysis: a pilot study. J Neuroeng Rehabil 2011; 8: 59
• 41 Sepulcre J et al. Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways. Mult Scler 2009; 15: 337-344
• 42 Simmons RD, Tribe KL, McDonald EA. Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management. J Neurol 2010; 257: 926-936
• 43 Stein H, Dettmers C. Fahreignung bei Multipler Sklerose. Dettmers C, Weiller C. Fahreignung bei neurologischen Krankheitsbildern. Hippocampus Verlag; 2003
• 44 Tallner A, Mäurer M, Pfeifer K. Körperliche Aktivität bei Personen mit Multipler Sklerose in Deutschland. Neurol Rehabil 2013; 19: 236-243
• 45 Tedeschi G et al. Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. J Neurol Sci 2007; 263: 15-19
• 46 Vieten MM, Sehle A, Jensen RL. A novel approach to quantify time series differences of gait data using attractor attributes. PLOS ONE 2013; 8: e71824-e71824
• 47 Yu HJ, Christodoulou C, Bhise V et al. Multiple white matter tract abnormalities underlie cognitive impairment in RRMS. Neuroimage 2012; 59: 3713-3722